Genelux Corporation (GNLX)
NASDAQ: GNLX · IEX Real-Time Price · USD
2.190
+0.270 (14.06%)
At close: Jul 26, 2024, 4:00 PM
2.150
-0.040 (-1.83%)
After-hours: Jul 26, 2024, 6:50 PM EDT
Genelux Market Cap
Genelux has a market cap or net worth of $75.23 million as of July 26, 2024. Its market cap has decreased by -91.02% in one year.
Market Cap
75.23M
Enterprise Value
57.97M
1-Year Change
-91.02%
Ranking
Category
Stock Price
$2.19
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $75.23M, a decrease of -46.91%. That is a compound annual growth rate of -34.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 51.80M | -86.16% |
| Dec 29, 2023 | 374.30M | 164.16% |
| Jan 26, 2023 | 141.69M | - |
View and export this data all the way back to 2023.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HeartBeam | 69.77M |
| Vivani Medical | 68.72M |
| SELLAS Life Sciences Group | 67.00M |
| Intensity Therapeutics | 66.51M |
| Theratechnologies | 66.44M |
| CEL-SCI | 65.53M |
| Champions Oncology | 65.39M |
| Burning Rock Biotech | 65.36M |